Stampidine
From Self-sufficiency
Revision as of 10:36, 11 September 2010 by حسن علي البط (Talk) (Adding category Category:Methyl esters (using HotCat))
File:Stampidine.png | |
Systematic (IUPAC) name | |
---|---|
methyl N-((4-bromophenoxy){[(2S,5R)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl]methoxy}phosphoryl)-D-alaninate | |
Identifiers | |
ATC code | none |
PubChem | CID 469782 |
Chemical data | |
Formula | C20H23BrN3O8P |
Molar mass | 544.289 g/mol[[Script error: No such module "String".]] |
Stampidine is an experimental nucleoside reverse transcriptase inhibitor (NRTI).
It is a derivative of d4T (stavudine, Zerit), and has been designed to avoid dependence on the rate limiting step of phosphorylation of stavudine to stavudine monophosphate. This is governed by the supply of thymidine kinase that is available, and stavudine is poorly phosphorylated to its monophosphate form in thymidine kinase-deficient cells. [1]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
50px | This antiinfective drug article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Nucleoside analog reverse transcriptase inhibitors
- Pyrimidinediones
- Dihydrofurans
- Organophosphorus
- Amino acid derivatives
- Organobromides
- Methyl esters
- Antiinfective agent stubs
- 2Fix